1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Vaccine Development Strategies - Refocusing Efforts to Address New Challenges

Vaccines are one of the most important healthcare advances and have saved millions of lives through immunizing against some of the most deadly diseases. With protection against a number of key viral and bacterial diseases now effectively generated, vaccine R&D is turning to areas of unmet need. Preventative vaccination in adults and against pathogens that affect the developing world is increasingly becoming a focus. Research into therapeutic vaccination for patients already affected by a disease is also gathering pace. There are several different approaches to preventative vaccination, most of which have been effectively employed to reduce the incidence of certain diseases or, in some cases, eradicate them completely.

Scope

- This report providers readers with an understanding of the key developing trends in the vaccines market and how these are expected to impact on the overall competitive landscape, the major players and forecasted growth
- This report provides an overview of the preventative vaccines market, including insights into clinical development strategies, recommendations for maximizing potential for development of preventative vaccines and discussion about potential areas of growth in the near term
- The report provides in-depth analysis of the developing landscape for therapeutic vaccines, including recent activities of major pharmaceutical companies, insight into the challenges being faced by companies developing therapeutic vaccines and recommendations on clinical development strategies to overcome these potential obstacles and hurdles
- The report assesses the evolving competitive vaccines landscape, profiling the major pharmaceutical players and providing information into the emerging vaccines companies and assessing how the vaccines market is expected to develop in the short to medium term.

Key Reasons to Purchase

- The report will enable you to understand how key factors such as the emerging markets, new therapeutic targets and innovative technologies are becoming increasingly important to profitability and commercial return for vaccine companies as traditional targets and populations become satisfied
- Gain insights on the key challenges that exist to further vaccine development
- Compare considerations in both therapeutic and preventive vaccines markets

Table Of Contents

Vaccine Development Strategies - Refocusing Efforts to Address New Challenges
Executive Summary
Methodology
Vaccines: an overview
Emerging trends
Key issues in vaccine development and marketing
Considerations in preventative vaccine development
Clinical trial considerations
Regulatory strategy
Market access
Developing world strategies
Considerations for therapeutic vaccine development
Therapy area focus
Clinical trial considerations
Regulatory strategy
Market access
Key players and commercial opportunity
Companies leading the way
Commercial opportunity
Appendix

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

  • $ 59500
  • Industry report
  • January 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.